• Annual General Meeting 2022

    May 25, 2022

  • Annual Report 2021

    April 28, 2022

Interview with Dr James Garner, CEO of Kazia Therapeutics

XR-17 is Vivesto’s proprietary delivery platform

CEO corner

Get to learn more about Francois Martelet, our CEO

Vivesto will publish its Q1 report for 2022 on May 25, 2022, at 08.00 am CET. The company will hold a conference call and an online presentation on the same day at 10.00 am CET. The call will be hosted by CEO Francois Martelet and CFO Fredrik Järrsten. The presentation will be in English and followed by a question-and-answer session.

The Share

Oasmia acquires global development and commercialization rights for Cantrixil, a clinical stage, ovarian cancer program

Annual Report 2021